Intrinsic activity at the molecular level: E. J. Ariëns' concept visualized.
The concept of using affinity and intrinsic activity to analyze drug interactions with receptors has had a long history in pharmacological studies. In the simplest case, the biological response will be proportional to the amount of drug bound, i.e. its affinity. However, the biological response is also mediated by the ability of a drug when bound to exert its maximum effectiveness. This effectiveness is termed the intrinsic activity. Physicochemical processes have been thought to be at the basis of intrinsic activity. Detailed oxygen and solution binding experiments combined with X-ray crystallographic studies on allosteric effectors to hemoglobin demonstrate that these potential drug agents bind at the same site in hemoglobin with similar binding constants yet shift the allosteric equilibrium and the oxygen affinity of the T-structure by different degrees. Therefore some of the effectors with similar binding affinities for the same site exhibit varying degrees of affectiveness, i.e. they possess different intrinsic activities. The intrinsic activity of the effector is defined as the ratio of the oxygen affinity constant to the T-state with drug/oxygen affinity constant to the T-state without drug (KT+drug)/(KT control). The source of the intrinsic activity appears to be the ability of the effectors to interact with key residues such as Lys99 alpha at the binding site. These results suggest a general molecular mechanism for allosteric effector modulation of hemoglobin function that might be of use in other allosteric enzyme systems.
Abraham
D J
DJ
Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond 23298, USA.
Kister
J
J
Joshi
G S
GS
Marden
M C
MC
Poyart
C
C
D000494:Allosteric Regulation / Q000187:drug effects; D000814:Aniline Compounds / Q000138:chemical synthesis / Q000494:pharmacology*; D006454:Hemoglobins / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D010100:Oxygen / Q000378:metabolism*; D010108:Oxyhemoglobins / Q000737:chemistry / Q000378:metabolism*; D011422:Propionates / Q000138:chemical synthesis / Q000494:pharmacology*; D012996:Solutions; D013329:Structure-Activity Relationship
D000814:Aniline Compounds; D006454:Hemoglobins; D010108:Oxyhemoglobins; D011422:Propionates; D012996:Solutions; C100003:deoxyhemoglobin; D010100:Oxygen